Brensocatib Patent Expiration
Brensocatib was first introduced by Insmed Inc
Brensocatib Patents
Given below is the list of patents protecting Brensocatib, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Brinsupri | US12059424 | Pharmaceutical Compositions Comprising (2S)-N-{(1S)-1-Cyano-2-[4-(3-Methyl-2-Oxo-2,3-Dihydro-1,3-Benzoxazol-5-Yl)Phenyl]Ethyl}-1,4-Oxazepane-2-Carboxamide | Feb 21, 2040 | Insmed Inc |
| Brinsupri | US12201638 | Pharmaceutical Compositions Comprising (2S)-N-{(1S)-1-Cyano-2-[4-(3-Methyl-2-Oxo-2,3-Dihydro-1,3-Benzoxazol-5-Yl)Phenyl]Ethyl}-1,4-Oxazepane-2-Carboxamide | Mar 01, 2039 | Insmed Inc |
| Brinsupri | US9522894 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides As Dipeptidyl Peptidase 1 Inhibitors | Mar 12, 2035 | Insmed Inc |
| Brinsupri | US10287258 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides As Dipeptidyl Peptidase 1 Inhibitors | Jan 21, 2035 | Insmed Inc |
| Brinsupri | US10669245 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides Dipeptidyl Peptidase 1 Inhibitors | Jan 21, 2035 | Insmed Inc |
| Brinsupri | US11655221 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides As Dipeptidyl Peptidase 1 Inhibitors | Jan 21, 2035 | Insmed Inc |
| Brinsupri | US11655222 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides As Dipeptidyl Peptidase 1 Inhibitors | Jan 21, 2035 | Insmed Inc |
| Brinsupri | US11655223 | Certain (2S)-N-[(1 S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides As Dipeptidyl Peptidase 1 Inhibitors | Jan 21, 2035 | Insmed Inc |
| Brinsupri | US11655224 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides As Dipeptidyl Peptidase 1 Inhibitors | Jan 21, 2035 | Insmed Inc |
| Brinsupri | US11673871 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides As Dipeptidyl Peptidase 1 Inhibitors | Jan 21, 2035 | Insmed Inc |
| Brinsupri | US11773069 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides As Dipeptidyl Peptidase 1 Inhibitors | Jan 21, 2035 | Insmed Inc |
| Brinsupri | US11814359 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides As Dipeptidyl Peptidase 1 Inhibitors | Jan 21, 2035 | Insmed Inc |
| Brinsupri | US12054465 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides As Dipeptidyl Peptidase 1 Inhibitors | Jan 21, 2035 | Insmed Inc |
| Brinsupri | US9815805 | Certain (25)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides As Dipeptidyl Peptidase 1 Inhibitors | Jan 21, 2035 | Insmed Inc |
Brensocatib's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List